BlackRock’s Vertex Pharmaceuticals VRTX Stock Holding History

BlackRock’s Portfolio VRTX Stock Details VRTX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$9.74B	Buy	21,871,945 +89,012	+0.4%	+$39.6M	0.19%	93
2025 Q1	$10.6B	Sell	21,782,933 -42,537	-0.2%	-$20.6M	0.22%	76
2024 Q4	$8.79B	Buy	21,825,470 +37,924	+0.2%	+$15.3M	0.18%	91
2024 Q3	$10.1B	Buy	21,787,546 +475,302	+2%	+$221M	0.21%	78
2024 Q2	$9.99B	Sell	21,312,244 -648,443	-3%	-$304M	0.23%	72
2024 Q1	$9.18B	Buy	21,960,687 +79,484	+0.4%	+$33.2M	0.21%	77
2023 Q4	$8.9B	Sell	21,881,203 -704,023	-3%	-$286M	0.23%	71
2023 Q3	$7.85B	Sell	22,585,226 -235,200	-1%	-$81.8M	0.23%	72
2023 Q2	$8.03B	Sell	22,820,426 -1,086,177	-5%	-$382M	0.22%	73
2023 Q1	$7.53B	Sell	23,906,603 -334,834	-1%	-$105M	0.22%	82
2022 Q4	$7B	Sell	24,241,437 -1,001,623	-4%	-$289M	0.22%	84
2022 Q3	$7.31B	Buy	25,243,060 +105,908	+0.4%	+$30.7M	0.25%	71
2022 Q2	$7.08B	Buy	25,137,152 +1,220,898	+5%	+$344M	0.23%	77
2022 Q1	$6.24B	Sell	23,916,254 -28,677	-0.1%	-$7.48M	0.17%	102
2021 Q4	$5.26B	Buy	23,944,931 +397,036	+2%	+$87.2M	0.13%	129
2021 Q3	$4.27B	Buy	23,547,895 +187,806	+0.8%	+$34.1M	0.12%	141
2021 Q2	$4.71B	Sell	23,360,089 -884,024	-4%	-$178M	0.13%	131
2021 Q1	$5.21B	Sell	24,244,113 -24,782	-0.1%	-$5.33M	0.15%	110
2020 Q4	$5.74B	Sell	24,268,895 -906,646	-4%	-$214M	0.18%	93
2020 Q3	$6.85B	Sell	25,175,541 -332,357	-1%	-$90.4M	0.25%	66
2020 Q2	$7.41B	Buy	25,507,898 +3,181,850	+14%	+$924M	0.3%	59
2020 Q1	$5.31B	Buy	22,326,048 +1,209,227	+6%	+$288M	0.26%	69
2019 Q4	$4.62B	Buy	21,116,821 +42,700	+0.2%	+$9.35M	0.18%	104
2019 Q3	$3.57B	Buy	21,074,121 +365,452	+2%	+$61.9M	0.15%	124
2019 Q2	$3.8B	Buy	20,708,669 +532,371	+3%	+$97.6M	0.16%	107
2019 Q1	$3.71B	Buy	20,176,298 +568,488	+3%	+$105M	0.17%	107
2018 Q4	$3.25B	Sell	19,607,810 -328,033	-2%	-$54.4M	0.16%	109
2018 Q3	$3.84B	Buy	19,935,843 +625,328	+3%	+$121M	0.17%	109
2018 Q2	$3.28B	Sell	19,310,515 -577,530	-3%	-$98.2M	0.15%	121
2018 Q1	$3.24B	Buy	19,888,045 +478,972	+2%	+$78.1M	0.15%	124
2017 Q4	$2.91B	Sell	19,409,073 -326,848	-2%	-$49M	0.14%	137
2017 Q3	$3B	Buy	19,735,921 +329,940	+2%	+$50.2M	0.15%	131
2017 Q2	$2.5B	Buy	19,405,981 +159,601	+0.8%	+$20.6M	0.13%	151
2017 Q1	$2.1B	Buy	19,246,380 +18,558,874	+2,699%	+$2.03B	0.12%	176
2016 Q4	$50.7M	Sell	687,506 -59,727	-8%	-$4.4M	0.07%	310
2016 Q3	$65.2M	Buy	747,233 +7,843	+1%	+$684K	0.09%	241
2016 Q2	$63.6M	Buy	739,390 +60,800	+9%	+$5.23M	0.1%	233
2016 Q1	$53.9M	Sell	678,590 -34,032	-5%	-$2.71M	0.09%	256
2015 Q4	$89.7M	Buy	712,622 +23,209	+3%	+$2.92M	0.13%	178
2015 Q3	$71.8M	Sell	689,413 -69,169	-9%	-$7.2M	0.11%	213
2015 Q2	$93.7M	Sell	758,582 -195,798	-21%	-$24.2M	0.14%	174
2015 Q1	$113M	Buy	954,380 +81,587	+9%	+$9.62M	0.16%	150
2014 Q4	$104M	Buy	872,793 +198,308	+29%	+$23.6M	0.15%	151
2014 Q3	$75.8M	Buy	674,485 +126,558	+23%	+$14.2M	0.11%	189
2014 Q2	$51.9M	Sell	547,927 -71,465	-12%	-$6.77M	0.08%	275
2014 Q1	$43.8M	Sell	619,392 -73,058	-11%	-$5.17M	0.07%	288
2013 Q4	$51.5M	Buy	692,450 +130,085	+23%	+$9.67M	0.08%	249
2013 Q3	$42.6M	Buy	562,365 +431,507	+330%	+$32.7M	0.08%	262
2013 Q2	$10.5M	Buy	+130,858	New	+$10.5M	0.02%	582